C101:XETRA:XETRA-Lyxor Fed Funds US Dollar Cash UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 99.422

Change

-0.99 (-0.99)%

Market Cap

USD 0.09B

Volume

225.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.01 (-0.03%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.01 (+0.06%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.05%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.38%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.06 (+0.22%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.07%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.32 (+0.22%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.10%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.76 (-0.71%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-6.12 (-1.00%)

USD 80.38B

ETFs Containing C101:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.55% 33% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.55% 33% F 33% F
Trailing 12 Months  
Capital Gain 5.27% 33% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.27% 31% F 37% F
Trailing 5 Years  
Capital Gain 7.69% 39% F 44% F
Dividend Return 1.53% 3% F 3% F
Total Return 9.22% 35% F 39% F
Average Annual (5 Year Horizon)  
Capital Gain 2.54% 36% F 37% F
Dividend Return 2.68% 36% F 37% F
Total Return 0.13% 19% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 7.67% 73% C 79% B-
Risk Adjusted Return 34.92% 37% F 42% F
Market Capitalization 0.09B 31% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.